Please login to the form below

Not currently logged in
Email:
Password:

P&G signs bioinformatics deal to speed new product research

Will use Eagle Genomics' software platform Eaglecore

edit-PG_logo 

Procter & Gamble (P&G) has signed a four-year agreement to use bioinformatics software to help boost the development of new products including pharmaceuticals, consumer goods and biofuels.

The firm will use Eagle Genomics' secure, cloud-based, Eaglecore platform to organise existing data and integrate existing data with new analysis from across the company.

Dr Abel Ureta-Vidal, CEO of Eagle, said: “Eaglecore is an extremely powerful platform and will have a major impact on P&G's approach to their current research projects.

“By using out platform, P&G will be able to better reference, manage and use all of their data to develop new insights and products, saving both time and development costs.”

The deal will see P&G take a four-year license for an undisclosed sum, which will include additional data curation services. The agreement follows a long partnership between the two companies involving Eagle's consultancy arm, which has been used to support past research.

Eagle, which allows large-scale genomics data and data generation technologies to be applied to world issues, was earlier this year awarded funding from the UK's Department of Health to develop proposals to help to with treating rare diseases and cancer.

Article by
Kirstie Pickering

12th December 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics